Should Higher Doses of Anti-Hepatitis B Virus (HBV) Therapy Be Considered Post-Liver Transplant (LTx) in HBV DNA Positive Recipients: A Case Report?

被引：0
|
作者：
Patel, Vishal [1 ]
Mukerji, Amar [1 ]
Karachristos, Andreas [1 ]
Maloo, Manoj [1 ]
Jain, Ashokkumar [1 ]
机构：
[1] TUHS, Philadelphia, PA USA
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [1] Effectiveness of post-transplant prophylaxis with anti-hepatitis B virus (HBV) immunoglobulin in heart transplant patients with anti-HBV core antibodies and in recipients of organs from HBV core antibody positive donors
    Cantarovich, M.
    Gianetti, N.
    Tchevenkov, J.
    Cyr, E.
    Cencic, D.
    Fontaine, G.
    Cecere, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S139 - S140
  • [2] HEPATITIS-B VIRAL (HBV) TRANSMISSION TO LIVER-TRANSPLANT (OLTX) RECIPIENTS BY LOW-LEVEL HBV DNA
    CHAZOUILLERES, O
    MAMISH, D
    CAREY, K
    FERRELL, L
    ROBERTS, J
    ASCHER, N
    WRIGHT, TL
    HEPATOLOGY, 1992, 16 (04) : A49 - A49
  • [3] LAMIVUDINE THERAPY OF FIBROSING CHOLESTATIC HEPATITIS (FCH) DUE TO RECURRENT HEPATITIS-B VIRUS (HBV) POST-LIVER TRANSPLANTATION (LT)
    WOOLF, GM
    VILLAMIL, FG
    PETROVIC, LM
    ROJTER, SE
    SHER, L
    MAKOWKA, L
    VICARY, C
    VIERLING, JM
    HEPATOLOGY, 1995, 22 (04) : 1615 - 1615
  • [4] Pre or post liver transplant (OLT) lamivudine therapy in patients with hepatitis B virus (HBV) replication.
    Picciotto, A
    Campo, N
    Caglieris, S
    Dardano, G
    Mondello, L
    Testa, R
    Valente, U
    Celle, G
    HEPATOLOGY, 1997, 26 (04) : 1813 - 1813
  • [5] Cost-Effectiveness of Utilization of Hepatitis B Virus-Positive Liver Donors for HBV-Negative Transplant Recipients
    Tiffany C. Lee
    Mark H. Eckman
    Shimul A. Shah
    Journal of Gastrointestinal Surgery, 2021, 25 : 1760 - 1769
  • [6] Cost-Effectiveness of Utilization of Hepatitis B Virus-Positive Liver Donors for HBV-Negative Transplant Recipients
    Lee, Tiffany C.
    Eckman, Mark H.
    Shah, Shimul A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (07) : 1760 - 1769
  • [7] Deep sequencing shows low-level oncogenic hepatitis B virus variants persists post-liver transplant despite potent anti-HBV prophylaxis
    Lau, K. C. K.
    Osiowy, C.
    Giles, E.
    Lusina, B.
    van Marle, G.
    Burak, K. W.
    Coffin, C. S.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (06) : 724 - 732
  • [8] Risk of Hepatitis B Virus (HBV) Reactivation and Role of Anti-Viral Prophylaxis in Lymphoma Patients with Past HBV Infection (HBV Antigen negative but anti-Hepatitis B core antibody positive) Receiving Chemo-Immunotherapy.
    Koo, Yu Xuan
    Tan, Shao Weng
    Tan, Bee Huat
    Tao, Miriam
    Chow, Wan Cheng
    Lim, Soon Thye
    BLOOD, 2008, 112 (11) : 1290 - 1290
  • [9] INTERFERON-ALPHA (IFN) FOR RECURRENT HEPATITIS-B (HBV) INFECTION POST-LIVER TRANSPLANT - RISKS AND BENEFITS
    TERRAULT, NA
    HOLLAND, C
    LAKE, JR
    ROBERTS, JP
    ASCHER, NL
    WRIGHT, TL
    GASTROENTEROLOGY, 1995, 108 (04) : A1185 - A1185
  • [10] Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV
    Zhang, Hang
    Wu, Lian-Ying
    Zhang, Shuai
    Qiu, Li-Yan
    Li, Nan
    Zhang, Xuan
    Zhang, Xue-Zhi
    Shan, Chang-Liang
    Ye, Li-Hong
    Zhang, Xiao-Dong
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
12345